Christopher M. Hilger
Known title: DirectorCIK: 0001895122
Christopher M. Hilger's purchase track record
Christopher M. Hilger has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/11/2023 | DCI | $200K | -0.2% | -2.4% | +6.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| DCI | ▲ Buy | Grant | 400 | $36K | 7/3/2026 | View on chart |
| DCI | ▲ Buy | Grant | 418 | $36K | 4/3/2026 | View on chart |
| DCI | ▲ Buy | Grant | 375 | $34K | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 900 | $0 | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 409 | $34K | 10/3/2025 | View on chart |
| DCI | ▲ Buy | Grant | 316 | $23K | 7/7/2025 | View on chart |
| DCI | ▲ Buy | Grant | 370 | $23K | 4/4/2025 | View on chart |
| DCI | ▲ Buy | Grant | 1,300 | $0 | 1/2/2025 | View on chart |
| DCI | ▲ Buy | Grant | 334 | $22K | 1/2/2025 | View on chart |
| DCI | ▲ Buy | Grant | 305 | $22K | 10/4/2024 | View on chart |
| DCI | ▲ Buy | Grant | 321 | $22K | 7/5/2024 | View on chart |
| DCI | ▲ Buy | Grant | 302 | $22K | 4/5/2024 | View on chart |
| DCI | ▲ Buy | Grant | 289 | $19K | 1/2/2024 | View on chart |
| DCI | ▲ Buy | Grant | 1,200 | $0 | 1/2/2024 | View on chart |
| DCI | ▲ Buy | Grant | 313 | $19K | 10/6/2023 | View on chart |
| DCI | ▲ Buy | Grant | 307 | $19K | 7/7/2023 | View on chart |
| DCI | ▲ Buy | Open Market | 3,186 | $200K | 4/11/2023 | View on chart |
| DCI | ▲ Buy | Grant | 307 | $19K | 4/7/2023 | View on chart |
| DCI | ▲ Buy | Grant | 318 | $19K | 1/3/2023 | View on chart |
| DCI | ▲ Buy | Grant | 1,300 | $0 | 1/3/2023 | View on chart |
| DCI | ▲ Buy | Grant | 370 | $19K | 10/7/2022 | View on chart |
| DCI | ▲ Buy | Grant | 386 | $19K | 7/1/2022 | View on chart |
| DCI | ▲ Buy | Grant | 355 | $19K | 4/1/2022 | View on chart |
| DCI | ▲ Buy | Grant | 298 | $17K | 1/3/2022 | View on chart |
| DCI | ▲ Buy | Grant | 1,200 | $0 | 1/3/2022 | View on chart |
| DCI | ▲ Buy | Grant | 100 | $0 | 12/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Morgan Stanley Raises DCI Target to $95 After Earnings Beat
Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.
Morgan Stanley Raises DCI Target to $95 After Earnings Beat. Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.